Terra Innovatum Global NV (NKLR) financial statements: income statement, balance sheet and cash flow
Terra Innovatum Global NV's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Terra Innovatum Global NV reported net income of $539.5M.
Income statement
Terra Innovatum Global NV income statement, fiscal years
Line item
Dec 31, 2025 · FY
General and administrative
$32.3M
Development costs
$1.4M
Total operating expenses
$33.7M
Loss from operations
($33.7M)
Other expense, net
($1.9M)
Interest expense
($1.4M)
Change in fair value - share settled contingent liability
560.0M
Change in fair value - warrant liabilities
$16.6M
Total other income, net
$573.2M
Income (loss) before income taxes
$539.5M
Net income (loss)
$539.5M
Change in foreign currency translation adjustment
($10.1M)
Total comprehensive income (loss)
$529.4M
Net income per share - basic (in Dollars per share)
$9.74
Weighted-average ordinary shares outstanding - basic (in Shares)
55.4M
Net income per share - diluted (in Dollars per share)
$9.74
Weighted-average ordinary shares outstanding - dilutive (in Shares)
55.4M
Terra Innovatum Global NV income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
General and administrative
$4.6M
$5.4M
$2.1M
Development costs
$1.5M
$1.2M
$155.0K
Total operating expenses
$6.1M
$6.6M
$2.3M
Loss from operations
($6.1M)
($6.6M)
($2.3M)
Other income (expenses)
$1.2M
—
—
Change in fair value - share settled contingent liability
-12.5M
-3.3M
—
Change in fair value - warrant liabilities
($663.0K)
$83.0K
—
Total other (expense) income, net
($12.0M)
($472.0K)
($697.0K)
Loss before income taxes
($18.0M)
($7.1M)
($3.0M)
Net loss
($18.0M)
($7.1M)
($3.0M)
Change in foreign currency translation adjustment
$1.2M
$2.0M
($49.0K)
Total comprehensive loss
($16.8M)
($5.1M)
($3.0M)
Net loss per share - basic (in Dollars per share)
-$0.16
-$0.06
—
Net loss per share - diluted (in Dollars per share)
-$0.16
-$0.06
—
Weighted-average ordinary shares outstanding - basic (in Shares)
110.2M
110.2M
—
Weighted-average ordinary shares outstanding – diluted (in Shares)
110.2M
110.2M
—
Balance sheet
Terra Innovatum Global NV balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Cash and cash equivalents
$102.9M
Accounts receivable, net
$4.0K
Prepaid expenses and other current assets
$3.1M
Total current assets
$106.0M
Equipment, net
$102.0K
Total assets
$106.1M
Accounts payable
$1.1M
Accrued expenses and other current liabilities
$2.0M
Total current liabilities
$3.2M
Share-settled contingent liability
186.3M
Warrant liabilities
$10.2M
Other non-current liabilities
$8.0K
Total liabilities
$199.7M
Ordinary shares (€0.01 par value, 500,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 110,226,198 shares issued and outstanding as of December 31, 2025 and 47,500,000 issued and outstanding as of December 31, 2024)
1.3M
Convertible Preferred Shares (€100 par value, 8,040 shares authorized as of December 31, 2025 and no shares authorized at December 31, 2024; 20 shares issued and outstanding as of December 31, 2025 and no issued and outstanding as of December 31, 2024)
3.1M
Additional paid-in capital
$519.4M
Accumulated deficit
($607.3M)
Accumulated other comprehensive income
($10.1M)
Total shareholders’ deficit
($93.6M)
Total liabilities and shareholders’ deficit
$106.1M
Terra Innovatum Global NV balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Cash and cash equivalents
$91.1M
$96.7M
$2.2M
Prepaid expenses and other current assets
$6.6M
$4.8M
$385.0K
Total current assets
$97.7M
$101.5M
$3.6M
Equipment, net
$455.0K
$417.0K
$98.0K
Operating lease right-of-use assets
$384.0K
—
—
Total assets
$98.5M
$101.9M
$3.7M
Accounts payable
$2.3M
$737.0K
$3.7M
Operating lease liabilities, current
$26.0K
—
—
Accrued expenses and other current liabilities
$4.3M
$4.0M
$221.0K
Total current liabilities
$6.6M
$4.8M
$7.5M
Share-settled contingent liability
196.5M
185.9M
—
Warrant liabilities
$10.5M
$9.9M
—
Operating lease liabilities, non-current
$358.0K
—
—
Other non-current liabilities
$38.0K
$27.0K
$167.0K
Total liabilities
$214.0M
$200.6M
$8.0M
Ordinary shares (€0.01 par value, 500,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 110,226,198 shares issued and outstanding as of June 30, 2026 and December 31, 2025)
1.3M
1.3M
—
Convertible Preferred Shares (€100 par value, 8,040 shares authorized as of June 30, 2026 and December 31, 2025; 20 shares issued and outstanding as of June 30, 2026 and December 31, 2025)
3.1M
3.1M
—
Additional paid-in capital
$519.4M
$519.4M
$1.4M
Accumulated deficit
($632.4M)
($614.4M)
($5.6M)
Accumulated other comprehensive loss
($6.9M)
($8.1M)
($30.0K)
Total shareholders' deficit
($115.5M)
($98.7M)
($4.2M)
Total liabilities and shareholders’ deficit
$98.5M
$101.9M
$3.7M
Cash flow statement
Terra Innovatum Global NV cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Net income (loss)
$539.5M
Unrealized foreign exchange gain
$54.0K
Loss on issuance of bridge loan and warrant liability
$1.4M
Change in fair value of warrants
($16.6M)
Change in fair value of share-settled contingent liability
-560.0M
Share-based compensation
$19.7M
Remeasurement of bridge loan
($16.0K)
Interest expense - non-cash
$1.4M
Depreciation expense
$10.0K
Issuance costs allocated to liability classified warrants
$9.0K
Prepaid expenses and other current assets
($2.7M)
Accounts receivable, net
($5.0K)
Accounts payable
$4.9M
Accrued expenses and other current liabilities
$1.9M
Other non-current liabilities
$2.0K
Net cash used in operating activities
($10.3M)
Purchases of equipment
($108.0K)
Net cash used in investing activities
($108.0K)
Proceeds from Bridge Loans
$5.7M
Payment of debt issuance costs for Bridge Loans
($24.0K)
Proceeds from Business Combination, net of transaction costs
$69.9M
Proceeds from PIPE financing
$36.8M
Payments to related party loans
($116.0K)
Net cash provided by financing activities
$112.3M
Effect of exchange rate changes on cash and cash equivalents
$955.0K
Net change in cash and cash equivalents
$101.9M
Cash and cash equivalents at beginning of the period
$69.0K
Cash and cash equivalents at end of the period
$102.9M
Initial value of warrant liabilities issued in connection with Bridge Loans
$5.7M
Conversion of Bridge Loans
$2.7M
Reclassification of excess of fair value of share-settled contingent liability over additional paid-in capital to accumulated deficit
1.1B
Issuance of Share-settled Contingent Liability
1.3B
Conversion of share-settled Contingent Liability into ordinary shares upon milestone achievement
514.5M
Issuance of ordinary shares and Advisor Warrant in exchange for services
14.0M
Terra Innovatum Global NV cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Net loss
($25.1M)
($7.1M)
($5.6M)
Unrealized foreign exchange (gain) loss
($872.0K)
($220.0K)
$15.0K
Change in fair value of warrants
$580.0K
($83.0K)
($1.3M)
Change in fair value of share-settled contingent liability
15.8M
3.3M
—
Depreciation expense
$14.0K
$6.0K
—
Prepaid expenses and other current assets
($3.6M)
($1.7M)
($290.0K)
Accounts receivable, net
$5.0K
$5.0K
—
Accounts payable
$2.0M
($178.0K)
$2.4M
Accrued expenses and other current liabilities
$2.4M
$2.1M
$245.0K
Other non-current liabilities
$25.0K
$17.0K
$97.0K
Net cash used in operating activities
($8.8M)
($3.9M)
($3.7M)
Purchases of equipment
($378.0K)
($328.0K)
($94.0K)
Net cash used in investing activities
($378.0K)
($328.0K)
($94.0K)
Effect of exchange rate changes on cash and cash equivalents
($2.7M)
($2.0M)
$105.0K
Net change in cash and cash equivalents
($9.2M)
($4.2M)
$2.0M
Cash and cash equivalents at beginning of the period
$102.9M
$102.9M
$69.0K
Cash and cash equivalents at end of the period
$91.1M
$96.7M
$2.2M
Cash paid for amounts included in the measurement of operating lease liabilities
$22.0K
—
—
Operating lease right-of-use assets obtained in exchange for operating lease liabilities